Showing results (611-620 of 1,962) with videos related to
Sort By:
Pageof 197
Expert Opinion on Drug Discovery|March 19, 2013
Designing PEGylated therapeutic molecules: advantages in ADMET propertiesMehrdad Hamidi, Pedram Rafiei, Amir AzadiExpert Opinion on Drug Discovery|March 19, 2013
Designing safe drugs: what to consider?Jeffrey A KramerExpert Opinion on Drug Discovery|March 19, 2013
The industrialisation of cellular screeningStephen Rees, Alan WiseExpert Opinion on Drug Discovery|March 19, 2013
Lead generation: reality check on commonly held viewsNader Fotouhi, Paul Gillespie, Robert GoodnowExpert Opinion on Drug Discovery|March 19, 2013
Non-cholinergic drug development for Alzheimer's diseaseRoy Yaari, Shubha Kumar, Pierre N TariotExpert Opinion on Drug Discovery|March 19, 2013
Second generation HIV protease inhibitors against resistant virusZhijian LuExpert Opinion on Drug Discovery|March 19, 2013
New small-molecule inhibitors of mitogen-activated protein kinase kinaseJulie A SpicerExpert Opinion on Drug Discovery|March 20, 2013
The ideal model in atherosclerosis and dyslipidaemia - does it exist?Keith SucklingExpert Opinion on Drug Discovery|March 20, 2013
Can pharmacoeconomics and ethics be balanced in drug research and development?Paolo PreziosiExpert Opinion on Drug Discovery|March 20, 2013
Anthracyclines as effective anticancer drugsJanos Nadas, Duxin SunPageof 197